Skip to main content

Intellectual Disability

1
Pipeline Programs
7
Companies
13
Clinical Trials
4 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

7 companies ranked by most advanced pipeline stage

Human BioSciences
Human BioSciencesWV - Martinsburg
7 programs
1
Methylphenidate Oral SolutionPhase 11 trial
Generic Best PracticesN/A1 trial
MEHMO Natural History and BiomarkersN/A1 trial
Physical Literacy & Food Literacy Intervention.N/A1 trial
PrefFCTN/A1 trial
+2 more programs
Active Trials
NCT04726371Completed415Est. Nov 2022
NCT06019182Recruiting150Est. Sep 2053
NCT04254666Completed6Est. Aug 2022
+4 more trials
Providence Therapeutics
1 program
Adapted Dialectical Behaviour TherapyN/A1 trial
Active Trials
NCT02919826Completed20Est. Mar 2018
CENTOGENE
CENTOGENEGermany - Rostock
1 program
Biomarker for Creatine Deficiency Syndromes (BioCDS)N/A1 trial
Active Trials
NCT02934854Withdrawn0Est. Feb 2021
Oregon Therapeutics
Oregon TherapeuticsFrance - Paris
1 program
Early Augmentative and Alternative CommunicationN/A1 trial
Active Trials
NCT05743439Unknown50Est. Dec 2025
Genomics
GenomicsUK - Oxford
1 program
Genomic sequencing and molecular diagnostic results, if any.N/A1 trial
Active Trials
NCT05471232Recruiting150Est. Jul 2027
Coordination Pharmaceuticals
1 program
Horticultural activityN/A1 trial
Active Trials
NCT07504874Not Yet Recruiting30Est. Dec 2026
Novo Nordisk
Novo NordiskBAGSVAERD DENMARK, Denmark
1 program
Physical activityN/A1 trial
Active Trials
NCT05336487Unknown85Est. Dec 2022

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
Human BioSciencesMethylphenidate Oral Solution
Coordination PharmaceuticalsHorticultural activity
Human BioSciencesPrefFCT
Human BioSciencesWeight Loss Plus Cooking
Human BioSciencesMEHMO Natural History and Biomarkers
GenomicsGenomic sequencing and molecular diagnostic results, if any.
Oregon TherapeuticsEarly Augmentative and Alternative Communication
Human BioSciencesGeneric Best Practices
Human BioSciencesPhysical Literacy & Food Literacy Intervention.
Novo NordiskPhysical activity
CENTOGENEBiomarker for Creatine Deficiency Syndromes (BioCDS)
Providence TherapeuticsAdapted Dialectical Behaviour Therapy
Human BioSciencesSedation Strategy and Cognitive Outcome After Critical Illness in Early Childhood

Clinical Trials (13)

Total enrollment: 1,508 patients across 13 trials

NCT05301361Human BioSciencesMethylphenidate Oral Solution

Sensitivity of the NIH Toolbox to Stimulant Treatment in Intellectual Disabilities

Start: Feb 2023Est. completion: Sep 202668 patients
Phase 1Enrolling By Invitation
NCT07504874Coordination PharmaceuticalsHorticultural activity

The Effect of Gardening Activities on the Quality of Life of Students With Mild Intellectual Disability

Start: May 2026Est. completion: Dec 202630 patients
N/ANot Yet Recruiting
NCT07278544Human BioSciencesPrefFCT

Harnessing Communication Preferences

Start: Aug 2025Est. completion: Mar 203160 patients
N/ARecruiting
NCT06961591Human BioSciencesWeight Loss Plus Cooking

Cooking Skills to Improve Long-Term Weight Loss in Young Adults With Intellectual Disabilities

Start: May 2025Est. completion: Jul 2029114 patients
N/ARecruiting
NCT06019182Human BioSciencesMEHMO Natural History and Biomarkers

MEHMO Natural History and Biomarkers

Start: Oct 2023Est. completion: Sep 2053150 patients
N/ARecruiting
NCT05471232GenomicsGenomic sequencing and molecular diagnostic results, if any.

Mental Health Crises in Youth With IDDs

Start: Mar 2023Est. completion: Jul 2027150 patients
N/ARecruiting
NCT05743439Oregon TherapeuticsEarly Augmentative and Alternative Communication

Early Augmentative and Alternative Communication (AAC) Intervention Delivered Via Hybrid Telehealth

Start: Jul 2022Est. completion: Dec 202550 patients
N/AUnknown
NCT04726371Human BioSciencesGeneric Best Practices

Best Practices to Prevent COVID-19 Illness in Staff and People With Serious Mental Illness and Developmental Disabilities in Congregate Living Settings

Start: Nov 2020Est. completion: Nov 2022415 patients
N/ACompleted
NCT04254666Human BioSciencesPhysical Literacy & Food Literacy Intervention.

New Skills - No Scores Research Study

Start: Jan 2020Est. completion: Aug 20226 patients
N/ACompleted
NCT05336487Novo NordiskPhysical activity

Physical Activity, Sports and Health in Adults With Intellectual Disabilities

Start: Aug 2019Est. completion: Dec 202285 patients
N/AUnknown
NCT02934854CENTOGENEBiomarker for Creatine Deficiency Syndromes (BioCDS)

Biomarker for Creatine Deficiency Syndromes (BioCDS)

Start: Aug 2018Est. completion: Feb 20210
N/AWithdrawn
NCT02919826Providence TherapeuticsAdapted Dialectical Behaviour Therapy

Dialectical Behaviour Group Therapy for Adults With Intellectual Disabilities

Start: Aug 2016Est. completion: Mar 201820 patients
N/ACompleted
NCT02225041Human BioSciencesSedation Strategy and Cognitive Outcome After Critical Illness in Early Childhood

Sedation Strategy and Cognitive Outcome After Critical Illness in Early Childhood

Start: Aug 2014Est. completion: Dec 2018360 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

4 actively recruiting trials targeting 1,508 patients
7 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.